Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck
region. The risk factors for development of cancers of the oral cavity, oropharynx …

Oral cavity is a gateway to the entire body and protection of this gateway is a major goal in
dentistry. Plaque biofilm is a major cause of majority of dental diseases and although …

Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal
sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and …

Background Targeting the programmed cell death protein 1 (PD-1)/programmed cell death
ligand 1 (PD-L1) axis has demonstrated clinical benefit in recurrent/metastatic head and …

Abstract Objective Silver nanoparticles (AgNPs) have been extensively studied for their
antimicrobial properties, which provide an extensive applicability in dentistry. Because of …

Squamous cell carcinoma of the oropharynx is increasing in incidence in epidemic
proportion. This site specific increase in incidence is due to an increase in human …

This review highlights the evidence-based data to support current best management
practices for patients with recurrent and/or metastatic (R/M) head and neck squamous cell …

Objective The monoclonal antibodies anti-programmed death protein-1 (anti–PD-1)
nivolumab and pembrolizumab are the first immune checkpoint inhibitors (ICIs) approved for …

Simple Summary Oral cancer is characterized by high morbidity and mortality, since the
disease is typically in an advanced locoregional stage at the time of diagnosis. The …

Human Papillomavirus (HPV) related oropharyngeal squamous cell carcinomas (OPSCCs)
are reported to have improved prognosis and survival in comparison to other head and neck …